Arkolith/Insider Trading/GALT/Form 4

Shlevin Harold H.

DirectorGALECTIN THERAPEUTICS INC (GALT) · full profile →Form 4 · filed Jun 30, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$151K
Net Open-Market Flow
-$151K
Transactions
6
4 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 29, 2026Option exercise(M)22K$1.23$27K29K
Jun 29, 2026Sell(S)22K$5.04$112K7K
Jun 26, 2026Option exercise(M)8K$1.23$10K14K
Jun 26, 2026Sell(S)8K$5.00$39K7K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jun 29, 2026Option exercise(M)22K—$030K
Jun 26, 2026Option exercise(M)8K—$052K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001133416-26-000061) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML